title: Review of naloxone safety for opioid overdose: practical considerations for new technology and expanded public access.
abstract: Opioid overdose and mortality have increased at an alarming rate prompting new public health initiatives to reduce drug poisoning. One initiative is to expand access to the opioid antidote naloxone. Naloxone has a long history of safe and effective use by organized healthcare systems and providers in the treatment of opioid overdose by paramedics/emergency medicine technicians, emergency medicine physicians and anesthesiologists. The safety of naloxone in a prehospital setting administered by nonhealthcare professionals has not been formally established but will likely parallel medically supervised experiences. Naloxone dose and route of administration can produce variable intensity of potential adverse reactions and opioid withdrawal symptoms: intravenous administration and higher doses produce more adverse events and more severe withdrawal symptoms in those individuals who are opioid dependent. More serious adverse reactions after naloxone administration occur rarely and may be confounded by the effects of other co-intoxicants and the effects of prolonged hypoxia. One component of the new opioid harm reduction initiative is to expand naloxone access to high-risk individuals (addicts, abusers, or patients taking high-dose or extended-release opioids for pain) and their close family or household contacts. Patients or their close contacts receive a naloxone prescription to have the medication on their person or in the home for use during an emergency. Contacts are trained on overdose recognition, rescue breathing and administration of naloxone by intramuscular injection or nasal spraying of the injection prior to the arrival of emergency medical personnel. The safety profile of naloxone in traditional medical use must be considered in this new context of outpatient prescribing, dispensing and treatment of overdose prior to paramedic arrival. New naloxone delivery products are being developed for this prehospital application of naloxone in treatment of opioid overdose and prevention of opioid-induced mortality.
authors: University of Kentucky College of Pharmacy, 789 South Limestone Street, Lexington, KY 40536, USA.
authors: Daniel P
authors: DP
authors: Wermeling
keywords: antidote; drug-delivery systems; naloxone; opioid; overdose
references: Am J Public Health. 2009 May;99(5):788-91
references: 19363214
references: Drug Deliv Transl Res. 2013 Feb 1;3(1):63-74
references: 23734342
references: N Engl J Med. 2012 Jul 12;367(2):146-55
references: 22784117
references: Ann Pharmacother. 2014 May;48(5):601-6
references: 24523396
references: J Toxicol Clin Toxicol. 1996;34(4):409-16
references: 8699555
references: Am J Addict. 2009 Jan-Feb;18(1):5-14
references: 19219660
references: Drug Alcohol Depend. 2007 Feb 23;87(1):98-102
references: 16959437
references: NCHS Data Brief. 2011 Dec;(81):1-8
references: 22617462
references: BMJ. 2013 Jan 30;346:f174
references: 23372174
references: Int J Pharm. 2007 Jun 7;337(1-2):1-24
references: 17475423
references: Addiction. 2009 Dec;104(12):2067-74
references: 19922572
references: Am J Emerg Med. 2010 Mar;28(3):296-303
references: 20223386
references: J Emerg Med. 2005 Oct;29(3):265-71
references: 16183444
references: Anesthesiology. 1976 May;44(5):398-401
references: 1267205
references: MMWR Morb Mortal Wkly Rep. 2012 Feb 17;61(6):101-5
references: 22337174
references: J Pediatr. 2012 Feb;160(2):265-270.e1
references: 21920539
references: Acad Emerg Med. 2003 Aug;10(8):893-6
references: 12896894
references: J Clin Psychiatry. 2010 Apr;71(4):491-6
references: 20409446
references: MMWR Morb Mortal Wkly Rep. 2014 Oct 10;63(40):881-5
references: 25299603
references: Ann Emerg Med. 2009 Apr;53(4):419-24
references: 18774623
references: J Opioid Manag. 2013 Sep-Oct;9(5):369-77
references: 24353049
references: J Subst Abuse Treat. 2013 Feb;44(2):241-7
references: 22980450
references: Med J Aust. 2005 Jan 3;182(1):24-7
references: 15651944
references: Mayo Clin Proc. 2014 Apr;89(4):462-71
references: 24629443
references: Prehosp Emerg Care. 2002 Jan-Mar;6(1):54-8
references: 11789651
references: Prehosp Emerg Care. 2006 Oct-Dec;10(4):468-71
references: 16997776
references: Addiction. 2008 Jan;103(1):126-36
references: 18028518
references: Prehosp Emerg Care. 1999 Jul-Sep;3(3):183-6
references: 10424852
references: MMWR Suppl. 2013 Nov 22;62(3):161-3
references: 24264508
references: Ann Emerg Med. 1990 Aug;19(8):902-5
references: 2372173
references: Ther Drug Monit. 2008 Aug;30(4):490-6
references: 18641540
references: Resuscitation. 2005 Jun;65(3):315-9
references: 15919568
references: Am J Prev Med. 2013 Dec;45(6):e19-25
references: 24237925
references: J Law Med Ethics. 2013 Mar;41 Suppl 1:33-6
references: 23590737
references: Acad Emerg Med. 1998 Apr;5(4):293-9
references: 9562190
references: Acad Emerg Med. 1996 Jul;3(7):660-7
references: 8816181
references: Addiction. 2008 Mar;103(3):379-86
references: 18269360
references: Eur J Emerg Med. 2004 Feb;11(1):19-23
references: 15167188
references: Prehosp Emerg Care. 2009 Oct-Dec;13(4):512-5
references: 19731165
references: Ann Emerg Med. 2007 Feb;49(2):172-7
references: 17141138
references: Lancet. 2013 Sep 7;382(9895):833
references: 24012254